Fabula
S2E22 · Shades of Gray

Targeting Pain: Isolating Sadness to Starve the Microbe

In Sickbay Pulaski and Troi confirm that sadness — not joy or anger — suppresses the vine-borne microbe. Encouraged by a faint dimming on the diagnostic panel, Pulaski recalibrates the neural stimulator to isolate memory-laden, intensely painful endorphin signatures. Troi’s empathic read provides the biochemical key; Pulaski elects an escalation that risks Riker’s stability. This moment is a turning point: it turns discovery into a dangerous tactic, establishing the medical strategy while foreshadowing the ethical and physiological cost to Riker.

Plot Beats

The narrative micro-steps within this event

2

Troi claims they can repel the infection, but Pulaski undercuts the relief with worsening vitals and a hard line against more tricordrazine, turning promise into a time-pressured risk calculus.

hope to urgent worry

Pulaski commits and refocuses the device to isolate stronger, pain-laced memories; current snaps through the circuit and RIKER jerks in reflex.

weighing risk to decisive action

Who Was There

Characters present in this moment

3

Cautiously optimistic and determined, masking concern; resolute in action but aware of potential harm to her patient.

Pulaski monitors the diagnostic readouts, weighs pharmacological risk, then decisively recalibrates the neural stimulator to emphasize memory patterns that produce intense negative emotion — taking a medical gamble to exploit the organism's biochemical weakness.

Goals in this moment
  • slow and reverse the organism's growth without unnecessary drug exposure
  • find a non‑pharmacological lever (emotionally driven endorphins) to inhibit the microbe
  • preserve Riker's life while minimizing systemic drug risk
Active beliefs
  • The organism's growth can be modulated by host biochemistry (endorphins).
  • Pharmacological options like tricordrazine are dangerous and should be avoided unless necessary.
  • Targeted neural stimulation of memory can safely (or at least effectively) produce usable biochemical responses.
Character traits
clinically decisive pragmatic risk‑tolerant underlying anxiety
Follow Katherine Pulaski's journey

Weakened and in pain; possibly resigned but trusting of the medical team, with limited capacity to influence decisions.

Riker is the passive subject of the treatment: his nervous system is monitored as Pulaski adjusts stimulation patterns; he makes a quick, reflexive movement when the current changes, and his vital signs are noted to be weakening, showing the physiological cost of the procedure.

Goals in this moment
  • survive the infection and treatment
  • rely on the medical team to make the right clinical choices
  • minimize further injury or distress
Active beliefs
  • The crew and medical officers will act in his best interest.
  • Enduring pain may be necessary for recovery.
  • He must tolerate discomfort to allow specialists to fight the infection.
Character traits
stoic under duress vulnerable compliant physically strained
Follow William Riker's journey

Encouraged and soberly invested — hopeful that the discovery offers a path but aware of Riker's fragility and the moral cost.

Troi provides an empathic read identifying Riker's dominant emotion as sadness, interprets the biochemical implication for Pulaski, and confirms the theory that different emotions produce distinct endorphin profiles which affect the organism.

Goals in this moment
  • accurately read and verbalize Riker's emotional state to guide treatment
  • ensure the emotional stimulation used will produce inhibitory endorphins rather than exacerbate the infection
  • support Pulaski's clinical decisions while advocating for Riker's wellbeing
Active beliefs
  • Her empathic impressions reliably correlate with biochemical states.
  • Specific emotions produce measurable endorphin responses that can be therapeutically exploited.
  • Emotional manipulation, even clinical, carries ethical weight and must be applied judiciously.
Character traits
empathic analytical supportive measured
Follow Deanna Troi's journey

Objects Involved

Significant items in this scene

2
Trisinov Medication

Tricordrazine is referenced as a pharmacological backup Pulaski is reluctant to administer further; its mention frames the risk calculus and motivates Pulaski to seek a non‑drug strategy (emotionally driven stimulation) instead of immediate additional dosing.

Before: Available in sickbay stores as a known but …
After: Still available but deliberately withheld as Pulaski pursues …
Before: Available in sickbay stores as a known but risky treatment option; not currently administered to Riker at this moment.
After: Still available but deliberately withheld as Pulaski pursues the neural stimulation strategy; remains a contingency should the emotional approach fail.
Sickbay Vital Signs Monitor Array

The bedside vital signs/neurological monitor displays a highlighted readout of Riker's nervous system; its subtle dimming provides the first empirical evidence that the organism's growth rate has slowed. The panel drives Pulaski's decision to alter stimulation parameters and confirms Troi's empathic read.

Before: Active, showing bright highlights indicating robust organism activity …
After: The highlight has dimmed slightly, signaling reduced growth …
Before: Active, showing bright highlights indicating robust organism activity across Riker's nervous system.
After: The highlight has dimmed slightly, signaling reduced growth rate; continues to monitor declining vital signs and influence treatment choices.

Location Details

Places and their significance in this event

1
Enterprise Sickbay

Enterprise sickbay functions as the clinical arena where empirical data, empathic insight, and medical risk converge. The space concentrates authority and intimacy: Pulaski's procedural control and Troi's bedside empathy turn the bay into a pressured surgical/thought laboratory where ethical choices are made under time stress.

Atmosphere Tense, clinically focused, quietly urgent — a pressure chamber of professional authority infused with personal …
Function Treatment theater and decision node for life‑saving interventions; a private refuge for Riker and an …
Symbolism Represents institutional responsibility and the moral weight of medical decision‑making; a crucible where personal loyalty …
Access Restricted to medical personnel and essential staff; not open to general crew in this moment.
cool overhead clinical lighting humming diagnostic consoles and holo readouts the faint mechanical hum of medical equipment a subtle change in panel illumination that signals clinical progress

Narrative Connections

How this event relates to others in the story

What led here 4
Causal

"Reliving Tasha’s death produces sadness that Pulaski registers as inhibiting microbial growth."

Parley, Refusal, and Sacrifice at the Shroud
S2E22 · Shades of Gray
Causal

"Reliving Tasha’s death produces sadness that Pulaski registers as inhibiting microbial growth."

Armus' Fatal Blow — Tasha Falls
S2E22 · Shades of Gray
Emotional Echo

"Ian’s death memory amplifies sorrow, reinforcing the observed slowdown in infection."

Ian Revealed — Source of the Threat
S2E22 · Shades of Gray
Emotional Echo

"Ian’s death memory amplifies sorrow, reinforcing the observed slowdown in infection."

When Medicine Fails: Ian's Release
S2E22 · Shades of Gray
What this causes 2
Escalation

"Pulaski tightens the current to target pain memories, then escalates to even harsher stimulation."

Fragile Stabilization — Tricordrazine Injection
S2E22 · Shades of Gray
Escalation

"Pulaski tightens the current to target pain memories, then escalates to even harsher stimulation."

Escalation: Tighten the Pattern
S2E22 · Shades of Gray

Key Dialogue

"PULASKI: The growth rate has definitely slowed. What is he feeling? Can you tell?"
"TROI: Sadness."
"PULASKI: I'm refocusing the pattern again. We need to isolate memories that generate stronger negative emotions."